Market Currents
United Therapeutics (UTHR) falls sharply after disclosing its late-stage drug for pulmonary...
-
Wednesday, August 24, 2011, 8:45 AM ETUnited Therapeutics (UTHR) falls sharply after disclosing its late-stage drug for pulmonary arterial hypertension failed to improving walking distance for patients. The firm says it will still move forward to seek FDA approval based on an earlier positive study. Shares down 21% premarket.
Other date
Latest Articles
